Beacon Financial Strategies CORP »

Humacyte shares owned by Beacon Financial Strategies CORP

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Beacon Financial Strategies CORP from 13F filings

Historical chart of Beacon Financial Strategies CORP investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Beacon Financial Strategies CORP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Beacon Financial Strategies CORP

Quarter filed Position value Share count Share price at filing
2025-12-31 $817 850 0.96

More positions owned by Beacon Financial Strategies CORP

Vanguard Index Fds Total Stk Mkt (VTI)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Us Equity Market (DFUS)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
International Business Machines (IBM)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)

View all positions for Beacon Financial Strategies CORP

Top funds holding Humacyte

BlackRock
Vanguard Group
Geode Capital Management
UBS Group
State Street Corporation
Woodline Partners
Susquehanna International
Two Sigma Investments
Charles Schwab Investment Management
Northern Trust
Millennium Management
Citadel Advisors
Bnp Paribas Arbitrage, Snc
LPL Financial
Barclays

View all funds holding Humacyte